Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Sep 23, 2024 2:24pm
89 Views
Post# 36236813

RE:RE:RE:Weekend update, lots to comment on

RE:RE:RE:Weekend update, lots to comment onPeladan, I feel sorry for anybody having lost somebody they love. But don't you dare try and conflate my disdain of ONCY management as being a lack of empathy for any one else suffering... I was an investor for over 20 years... and in that time ONCY has been going around in nothing but circles...

So listen up and let me put your straight on a few facts, that you seem too ignorant or thick to grasp..

Brad (CEO) was touting approval by 2005 at one point, and Matt by 2023. Yet they cocked up trial after trial, confounding issues here, spats with KOLs there... disappeared trials (remember the collaboration with Revlimid) simply disappeared without let or hindrance, but I digress.

ONCY hasn't demonstrated clinical proof of efficacy to the satisifaction of ANY regulatory agency, ANYWHERE in the world in over 25 years of operations, and yet it only has one product,

ONCY didn't even know (by their own admission) how its product worked for 15 years, so how could they have designed a trial to show it worked.. and the patients they treated COULD have recieved some other treatment option that worked and be alive today.

ONCY received a SPA for a Phase III Pela + Pax combo trial 6 1/2 years ago... a trial which by now would have finished, and had it been approved, ONCY would be treating these patients, that you claim I don't care about... and now they're gooing to repeat that in a phase II for a third time.

If you're as brainless as you come across, then you deserve to lose everything you've invested in this po s company. There are enough posters flashing warning signals for you... 

I'm not trashing ONCY, I'm posting valid concerns and asking questions. Are you naive enough to think that a single persons posts are the cause of ONCY pps malaise... how dumb do you have to be, not to see how ONCY management are fully culpable for the litany of failures behind them..

Do you actually think that taking 30 years to get a single treatment approved (if ever it's approved) is the sign of good management and good science.??

How may cancer patients have passed away in the time these clowns will have taken to get a treatment to market. Let's just hope you don't need Pela in the next 5 years eh...
.

 
<< Previous
Bullboard Posts
Next >>